| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.06 |